
### [NCIT:C9105](http://purl.obolibrary.org/obo/NCIT_C9105)
**Label:** Oropharyngeal Carcinoma

**Subclasses:** [NCIT:C6039](http://purl.obolibrary.org/obo/NCIT_C6039) (Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7), [NCIT:C8218](http://purl.obolibrary.org/obo/NCIT_C8218) (Stage II Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7), [NCIT:C8219](http://purl.obolibrary.org/obo/NCIT_C8219) (Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7), [NCIT:C8217](http://purl.obolibrary.org/obo/NCIT_C8217) (Stage I Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7), [NCIT:C4590](http://purl.obolibrary.org/obo/NCIT_C4590) (Stage 0 Oropharyngeal Carcinoma AJCC v6 and v7), [NCIT:C91248](http://purl.obolibrary.org/obo/NCIT_C91248) (Oropharyngeal Carcinoma by AJCC v7 Stage), [NCIT:C87055](http://purl.obolibrary.org/obo/NCIT_C87055) (Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma), [NCIT:C68610](http://purl.obolibrary.org/obo/NCIT_C68610) (Oropharyngeal Undifferentiated Carcinoma), [NCIT:C8181](http://purl.obolibrary.org/obo/NCIT_C8181) (Oropharyngeal Squamous Cell Carcinoma), [NCIT:C9218](http://purl.obolibrary.org/obo/NCIT_C9218) (Stage IV Oropharyngeal Carcinoma AJCC v6), [NCIT:C8049](http://purl.obolibrary.org/obo/NCIT_C8049) (Stage II Oropharyngeal Carcinoma AJCC v6 and v7), [NCIT:C115089](http://purl.obolibrary.org/obo/NCIT_C115089) (Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C8048](http://purl.obolibrary.org/obo/NCIT_C8048) (Stage I Oropharyngeal Carcinoma AJCC v6 and v7), [NCIT:C115088](http://purl.obolibrary.org/obo/NCIT_C115088) (Stage III Oropharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C115087](http://purl.obolibrary.org/obo/NCIT_C115087) (Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7), [NCIT:C8221](http://purl.obolibrary.org/obo/NCIT_C8221) (Recurrent Oropharyngeal Squamous Cell Carcinoma), [NCIT:C115086](http://purl.obolibrary.org/obo/NCIT_C115086) (Stage I Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7), [NCIT:C6241](http://purl.obolibrary.org/obo/NCIT_C6241) (Oropharyngeal Adenoid Cystic Carcinoma), [NCIT:C8220](http://purl.obolibrary.org/obo/NCIT_C8220) (Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7), [NCIT:C115093](http://purl.obolibrary.org/obo/NCIT_C115093) (Recurrent Oropharyngeal Undifferentiated Carcinoma), [NCIT:C8050](http://purl.obolibrary.org/obo/NCIT_C8050) (Stage III Oropharyngeal Carcinoma AJCC v6), [NCIT:C8051](http://purl.obolibrary.org/obo/NCIT_C8051) (Recurrent Oropharyngeal Carcinoma), [NCIT:C90523](http://purl.obolibrary.org/obo/NCIT_C90523) (Oropharyngeal Carcinoma by AJCC v6 Stage), [NCIT:C126751](http://purl.obolibrary.org/obo/NCIT_C126751) (Oropharyngeal Basaloid Carcinoma), [NCIT:C126750](http://purl.obolibrary.org/obo/NCIT_C126750) (Oropharyngeal Poorly Differentiated Carcinoma), [NCIT:C89023](http://purl.obolibrary.org/obo/NCIT_C89023) (Stage IV Oropharyngeal Carcinoma AJCC v7), [NCIT:C89021](http://purl.obolibrary.org/obo/NCIT_C89021) (Stage III Oropharyngeal Carcinoma AJCC v7), 

**Class expressions from DL-Learner:**

- Thing 53.10%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40147](http://purl.obolibrary.org/obo/NCIT_C40147) (Grade 2 Endometrial Endometrioid Adenocarcinoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40146](http://purl.obolibrary.org/obo/NCIT_C40146) (Grade 1 Endometrial Endometrioid Adenocarcinoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40142](http://purl.obolibrary.org/obo/NCIT_C40142) (Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40141](http://purl.obolibrary.org/obo/NCIT_C40141) (Wolffian Adnexal Tumor))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40139](http://purl.obolibrary.org/obo/NCIT_C40139) (Uterine Ligament Clear Cell Adenocarcinoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40138](http://purl.obolibrary.org/obo/NCIT_C40138) (Uterine Ligament Endometrioid Adenocarcinoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40137](http://purl.obolibrary.org/obo/NCIT_C40137) (Uterine Ligament Mucinous Adenocarcinoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40129](http://purl.obolibrary.org/obo/NCIT_C40129) (Fallopian Tube Adenomatoid Tumor))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40128](http://purl.obolibrary.org/obo/NCIT_C40128) (Fallopian Tube Leiomyosarcoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40127](http://purl.obolibrary.org/obo/NCIT_C40127) (Fallopian Tube Leiomyoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40125](http://purl.obolibrary.org/obo/NCIT_C40125) (Fallopian Tube Adenosarcoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40124](http://purl.obolibrary.org/obo/NCIT_C40124) (Fallopian Tube Carcinosarcoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40122](http://purl.obolibrary.org/obo/NCIT_C40122) (Pelvic Pain))) 38.69%


